17,20-lyase
17,20-lyase, also known as CYP17A1, is a monooxygenase that catalyzes many reactions involved in drug metabolism and synthesis of cholesterol, steroids, and other lipids.
Products Related to 17,20-lyase(4)
- GC50209S4CAS: 1330061-67-0Purity: >98%
S4 is a potent and selective inhibitor of carbonic anhydrase IX/XII (CA IX/XII), with a Ki of 7 nM and 2 nM, respectively. S4 also inhibits CA II and CA I (Ki=546 and 5600 nM, respectively). S4 can inhibit the number of lung metastasis in orthotopic MDA-MB-231 mouse model without affecting primary tumor growth.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC16886 | Orteronel | 566939-85-3 | >99.50% | |
A non-steroidal inhibitor of the 17,20-lyase activity of CYP17A1 | ||||
| GC18123 | TAK-700 salt | 426219-53-6 | >98% | |
Androgen synthesis inhibitor | ||||
| GC50209 | S4 | 1330061-67-0 | >98% | |
S4 is a potent and selective inhibitor of carbonic anhydrase IX/XII (CA IX/XII), with a Ki of 7 nM and 2 nM, respectively. S4 also inhibits CA II and CA I (Ki=546 and 5600 nM, respectively). S4 can inhibit the number of lung metastasis in orthotopic MDA-MB-231 mouse model without affecting primary tumor growth. | ||||
| GC50336 | SHIP 2a | 2165706-30-7 | >99.00% | |
SHIP 2a is a selective cystathionine γ-lyase (CSE) enzyme inhibitor with an IC50 of 6.3 μM. | ||||